Covid-19 (Coronavirus disease 2019) is the acute respiratory syndrome caused by SARS-CoV-2 coronavirus. Under the guidance and support of Vietnam's Ministry of Health and Ministry of Science & Technology, Nanogen Pharmaceutical Biotechnology JSC has researched and developed a SARS-CoV-2 vaccine candidate - NANO COVAX – based on recombinant protein technology.
NANO COVAX accomplished pre-clinical trials and was approved by authorities to conduct a clinical trial from December 10th, 2020. The clinical trial consists of 3 phases. Currently, Nanogen in coordination with Vietnam Military Medical University sincerely announces the recruitment for volunteers of Phase 1 and Phase 2.
- Phase 1 is expected to test on 60 volunteers (aged from 18-50), starting from 10/12/2020 in Vietnam Military Medical University (160 Phung Hung, Phuc La Ward, Ha Dong District, Ha Noi)
- Phase 2 is expected to test on 400-600 volunteers (aged from 12-75), starting after Phase 1 in Vietnam Military Medical University and other sites that will are approved by Ministry of Health.
The volunteers taking part in the clinical trial will be screened and selected is qualified the criteria, they will be supervised following the standard process.
By volunteering to participate in this trial, you will contribute to the process of bringing the Covid-19 vaccine developed by a Vietnam company into the community!
------------------------------
How to register:
1. Register offline at Clinical trials and Bio-equivalent Center, Vietnam Military University (160 Phung Hung, Phuc La Ward, Ha Dong District, Ha Noi)
2. Via phone:
Dr. Tran Ba Hieu – (+84) 388 959 096
Dr. Chu Van Men – (+84) 362 359 084/ (+84) 353 212 500
3. Via email: nanocovax@nanogenpharma.com
Please send the information including Full name, Date of birth, Permanent residence, Current address, Identity number, phone and email address.
